Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intra-Cellular Ther
(NQ:
ITCI
)
72.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
72.00
Bid (Size)
71.00 (1)
Ask (Size)
73.63 (1)
Prev. Close
72.00
Today's Range
72.00 - 72.00
52wk Range
45.50 - 84.89
Shares Outstanding
94,324,313
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
April 17, 2024
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via
Benzinga
Performance
YTD
+2.14%
+2.14%
1 Month
+10.01%
+10.01%
3 Month
+10.53%
+10.53%
6 Month
+44.75%
+44.75%
1 Year
+16.04%
+16.04%
More News
Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 16, 2024
Via
Benzinga
8 Analysts Assess Intra-Cellular Therapies: What You Need To Know
April 03, 2024
Via
Benzinga
Where Intra-Cellular Therapies Stands With Analysts
February 23, 2024
Via
Benzinga
Analyst Scoreboard: 8 Ratings For Intra-Cellular Therapies
January 18, 2024
Via
Benzinga
Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study
April 16, 2024
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
April 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intra-Cellular Therapies Inc. (NASDAQ: ITCI) Climbs to New 52-Week High
April 16, 2024
Via
Investor Brand Network
Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
April 16, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Intra-Cellular Therapies
January 02, 2024
Via
Benzinga
Expert Ratings for Intra-Cellular Therapies
December 11, 2023
Via
Benzinga
Intra-Cellular Therapies's Earnings: A Preview
November 01, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
February 21, 2024
Via
InvestorPlace
Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals
December 29, 2023
Via
MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
Via
Benzinga
What 10 Analyst Ratings Have To Say About Intra-Cellular Therapies
August 22, 2023
Via
Benzinga
Analyst Expectations for Intra-Cellular Therapies's Future
August 03, 2023
Via
Benzinga
Needham Maintains Buy Rating for Intra-Cellular Therapies: Here's What You Need To Know
July 06, 2023
Via
Benzinga
Analyst Expectations for Intra-Cellular Therapies's Future
June 22, 2023
Via
Benzinga
Are These Biotechs Ready To Launch?
December 09, 2023
Via
Talk Markets
Intra-Cellular Therapies Better Positioned For Success: Analyst Anticipates Positive Phase 3 Depression Trial Data
July 06, 2023
Via
Benzinga
Analyst Expectations for Intra-Cellular Therapies's Future
June 05, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.